stockrow
Friday 6 November 2026
Export SDGR’s income statement to Excel — free account
Schrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
29.96
1.19
+4.14%
Follow SDGR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 3 | 3 | 4 |
| (26.29%) | (30.12%) | (16.18%) | (19.02%) | ||
| (13.33%) | (15.03%) | (8.18%) | (9.36%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(29.54%) | (32.87%) | (17.19%) | (19.15%) | |
Average Days of Receivables |
148.92 | 68.99 | 57.95 | 0.00 | |
Free Cash Flow per Share |
0.17 | (2.00) | (1.74) | (1.56) | |
Free Cash Flow |
12.46 | (148.35) | (130.27) | (116.77) | |
Capital Expenditures |
(1.44) | (3.35) | (3.40) | (4.20) | |
| Other line items | |||||
Cash ROIC |
1.63% | (20.61%) | (17.42%) | (17.29%) | |
Accounts Receivable Turnover |
1.42 | 5.39 | 6.65 | 0.00 | |
Accounts Payable Turnover |
10.24 | 9.57 | 11.69 | 13.01 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
36.91 | 38.29 | 33.72 | 25.97 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.01 | 0.01 | 0.05 | 0.04 | |
Research and Development Expense of Revenue |
67.67% | 67.13% | 65.23% | 59.55% | |
Selling, General and Administrative Expense of Revenue |
53.30% | 52.85% | 50.87% | 48.60% | |
Share Based Compensation of Revenue |
16.80% | 15.89% | 14.93% | 13.28% | |
Operating CF/Net income |
(0.13) | 1.40 | 2.34 | 1.90 | |
Depreciation/Fixed assets |
0.31 | 0.29 | 0.30 | 0.31 | |
Capex/Depreciation |
(0.24) | (0.57) | (0.58) | (0.72) | |
Revenue per Share |
3.48 | 3.45 | 3.47 | 3.60 | |
Operating CF per Share |
0.19 | (1.96) | (1.70) | (1.50) | |
Capex per Share |
(0.02) | (0.05) | (0.05) | (0.06) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 |
Columns are period end dates · fundamentals updated 4 Nov 2026